Factors associated with sight threatening lesions of leprosy in patients on multidrug therapy.
One hundred and six consecutive patients (old and newly diagnosed) attending the leprosy clinic at Guru Teg Bahadur Hospital, Delhi, underwent a detailed ophthalmic examination to identify factors associated with the prevalence of sight threatening lesions of leprosy so as to delineate a sub-group of patients who should continue under active ophthalmic surveillance to prevent blindness. All of them were receiving multidrug therapy as recommended by WHO. Demographic data, systemic parameters and ophthalmic lesions attributable to the disease were endorsed on to a proforma. The data were analysed by chi-square test, discriminant analysis and multivariate regression analysis to isolate factors that could be associated with sight threatening lesions of leprosy. In 106 leprosy patients 212 eyes were examined; sight threatening lesions were found in 37 eyes (17.4%). The comea was involved most commonly (78.3%). The lesions were still present in 15.8% of patients who had completed multidrug therapy. Leprosy related visual impairment was seen in 2.3% eyes and blindness in 0.9% eyes. Factors significantly associated with sight threatening lesions included female gender, multibacillary leprosy, increasing duration of leprosy, thickened corneal nerves, subepithelial punctate corneal opacities and presence of any academic lesion of leprosy. On multivariate and discriminant analysis, female gender, thickened corneal nerves and duration of leprosy > 7 years were significantly associated with sight threatening lesions.
Rohatgi
J
J
Department of Ophthalmology, University College of Medical Sciences, Guru Teg Bahadur Hospital, Delhi.
Dhaliwal
U
U
Singal
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D001766:Blindness / Q000453:epidemiology / Q000209:etiology*; D002648:Child; D018450:Disease Progression; D005260:Female; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D007918:Leprosy / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D019338:Polypharmacy; D012307:Risk Factors